Remove condition epilepsy
article thumbnail

‘The worst I’ve known it’: the struggle to get vital medicines in the UK

The Guardian - Pharmaceutical Industry

Four people with conditions that require consistent medication explain how the shortages have affected their wellbeing NHS medicines shortage putting people at risk, pharmacists warn Analysis: why is UK being hit by medicine supply shortages?

94
article thumbnail

Abortion Ban Could Be Life-Threatening for Women With Neurological Conditions

Pharmacy Times

Researchers highlight how a lack of access to medications used to treat multiple sclerosis, migraines, and epilepsy, but not proven safe for pregnancy, threatens child-bearing aged women who live with these conditions.

139
139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Researchers identify new treatment target for genetic epilepsy

Pharma Times

The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy

56
article thumbnail

Drug-resistant epilepsy drug Ontozry backed by NICE

pharmaphorum

NHS patients in England and Wales with drug-resistant epilepsy are in line for access to another treatment option, after NICE recommended routine use of Angelini group company Arvelle Pharma’s Ontozry. Epilepsy affects more than 600,000 people in the UK and for some, seizures can be life-threatening.

article thumbnail

Recent advances in neurological disorders

pharmaphorum

Thirdly, we aim to create the best possible experience for patients to help them navigate through the complexity of their condition and all its consequences.”. Unmet needs in epilepsy. Beyond epilepsy, there is a range of further neurological disorders that are becoming increasingly well-understood.

article thumbnail

Benefits of Medical Marijuana for Epilepsy

BuzzRx

Medical marijuana (cannabis) has been studied to treat several neuropsychiatric disorders and health conditions, such as Alzheimer’s disease , multiple sclerosis , HIV/AIDS , Crohn’s disease, glaucoma, and epileptic seizures. Please continue reading to learn more about the use of medical marijuana for epilepsy treatment.

FDA 64
article thumbnail

Neuraxpharm partners with mjn-neuro on epilepsy wearable

pharmaphorum

German specialty drugmaker Neuraxpharm has licensed commercial rights in Europe to a wearable device developed by Spanish start-up mjn-neuro that is designed to warn a person with epilepsy about an impending seizure. ” The post Neuraxpharm partners with mjn-neuro on epilepsy wearable appeared first on. .